Synthetic 1,4-pyran naphthoquinones are potent inhibitors of dengue virus replication. 2013

Emmerson C B da Costa, and Raquel Amorim, and Fernando C da Silva, and David R Rocha, and Michelle P Papa, and Luciana B de Arruda, and Ronaldo Mohana-Borges, and Vitor F Ferreira, and Amilcar Tanuri, and Luciana J da Costa, and Sabrina B Ferreira
Laboratório de Genômica Estrutural, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.

Dengue virus infection is a serious public health problem in endemic areas of the world where 2.5 billion people live. Clinical manifestations of the Dengue infection range from a mild fever to fatal cases of hemorrhagic fever. Although being the most rapidly spreading mosquito-borne viral infection in the world, until now no strategies are available for effective prevention or control of Dengue infection. In this scenario, the development of compounds that specifically inhibit viral replication with minimal effects to the human hosts will have a substantial effect in minimizing the symptoms of the disease and help to prevent viral transmission in the affected population. The aim of this study was to screen compounds with potential activity against dengue virus from a library of synthetic naphthoquinones. Several 1,2- and 1,4-pyran naphthoquinones were synthesized by a three-component reaction of lawsone, aldehyde (formaldehyde or arylaldehydes) and different dienophiles adequately substituted. These compounds were tested for the ability to inhibit the ATPase activity of the viral NS3 enzyme in in vitro assays and the replication of dengue virus in cultured cells. We have identified two 1,4-pyran naphthoquinones, which inhibited dengue virus replication in mammal cells by 99.0% and three others that reduced the dengue virus ATPase activity of NS3 by two-fold in in vitro assays.

UI MeSH Term Description Entries
D009285 Naphthoquinones Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups. Naphthalenediones,Naphthazarins,Naphthoquinone
D011714 Pyrans Pyran
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D003716 Dengue Virus A species of the genus FLAVIVIRUS which causes an acute febrile and sometimes hemorrhagic disease in man. Dengue is mosquito-borne and four serotypes are known. Breakbone Fever Virus,Breakbone Fever Viruses,Dengue Viruses,Fever Virus, Breakbone,Fever Viruses, Breakbone,Virus, Breakbone Fever,Virus, Dengue,Viruses, Breakbone Fever,Viruses, Dengue
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000251 Adenosine Triphosphatases A group of enzymes which catalyze the hydrolysis of ATP. The hydrolysis reaction is usually coupled with another function such as transporting Ca(2+) across a membrane. These enzymes may be dependent on Ca(2+), Mg(2+), anions, H+, or DNA. ATPases,Adenosinetriphosphatase,ATPase,ATPase, DNA-Dependent,Adenosine Triphosphatase,DNA-Dependent ATPase,DNA-Dependent Adenosinetriphosphatases,ATPase, DNA Dependent,Adenosinetriphosphatases, DNA-Dependent,DNA Dependent ATPase,DNA Dependent Adenosinetriphosphatases,Triphosphatase, Adenosine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

Emmerson C B da Costa, and Raquel Amorim, and Fernando C da Silva, and David R Rocha, and Michelle P Papa, and Luciana B de Arruda, and Ronaldo Mohana-Borges, and Vitor F Ferreira, and Amilcar Tanuri, and Luciana J da Costa, and Sabrina B Ferreira
July 2003, Bioorganic & medicinal chemistry,
Emmerson C B da Costa, and Raquel Amorim, and Fernando C da Silva, and David R Rocha, and Michelle P Papa, and Luciana B de Arruda, and Ronaldo Mohana-Borges, and Vitor F Ferreira, and Amilcar Tanuri, and Luciana J da Costa, and Sabrina B Ferreira
May 2016, Chemical biology & drug design,
Emmerson C B da Costa, and Raquel Amorim, and Fernando C da Silva, and David R Rocha, and Michelle P Papa, and Luciana B de Arruda, and Ronaldo Mohana-Borges, and Vitor F Ferreira, and Amilcar Tanuri, and Luciana J da Costa, and Sabrina B Ferreira
January 1984, Arzneimittel-Forschung,
Emmerson C B da Costa, and Raquel Amorim, and Fernando C da Silva, and David R Rocha, and Michelle P Papa, and Luciana B de Arruda, and Ronaldo Mohana-Borges, and Vitor F Ferreira, and Amilcar Tanuri, and Luciana J da Costa, and Sabrina B Ferreira
December 2004, The Journal of biological chemistry,
Emmerson C B da Costa, and Raquel Amorim, and Fernando C da Silva, and David R Rocha, and Michelle P Papa, and Luciana B de Arruda, and Ronaldo Mohana-Borges, and Vitor F Ferreira, and Amilcar Tanuri, and Luciana J da Costa, and Sabrina B Ferreira
December 2024, Journal of enzyme inhibition and medicinal chemistry,
Emmerson C B da Costa, and Raquel Amorim, and Fernando C da Silva, and David R Rocha, and Michelle P Papa, and Luciana B de Arruda, and Ronaldo Mohana-Borges, and Vitor F Ferreira, and Amilcar Tanuri, and Luciana J da Costa, and Sabrina B Ferreira
January 1970, Journal of medicinal chemistry,
Emmerson C B da Costa, and Raquel Amorim, and Fernando C da Silva, and David R Rocha, and Michelle P Papa, and Luciana B de Arruda, and Ronaldo Mohana-Borges, and Vitor F Ferreira, and Amilcar Tanuri, and Luciana J da Costa, and Sabrina B Ferreira
December 2003, FEBS letters,
Emmerson C B da Costa, and Raquel Amorim, and Fernando C da Silva, and David R Rocha, and Michelle P Papa, and Luciana B de Arruda, and Ronaldo Mohana-Borges, and Vitor F Ferreira, and Amilcar Tanuri, and Luciana J da Costa, and Sabrina B Ferreira
January 2014, Bioorganic & medicinal chemistry letters,
Emmerson C B da Costa, and Raquel Amorim, and Fernando C da Silva, and David R Rocha, and Michelle P Papa, and Luciana B de Arruda, and Ronaldo Mohana-Borges, and Vitor F Ferreira, and Amilcar Tanuri, and Luciana J da Costa, and Sabrina B Ferreira
September 2023, Viruses,
Emmerson C B da Costa, and Raquel Amorim, and Fernando C da Silva, and David R Rocha, and Michelle P Papa, and Luciana B de Arruda, and Ronaldo Mohana-Borges, and Vitor F Ferreira, and Amilcar Tanuri, and Luciana J da Costa, and Sabrina B Ferreira
August 2008, Organic & biomolecular chemistry,
Copied contents to your clipboard!